Безопасен ли behenamide при беременности?

Related ingredients

Frequently asked questions

Безопасен ли behenamide при беременности?

No harmonised CLP classification nor SCCS/CIR reproductive safety assessment was found for docosanamide (behenamide, CAS 3061-75-4). ECHA registration dossier and read-across justification conclude reproductive toxicity studies are not triggered and no reproductive hazard is indicated. ([echa.europa.eu](https://echa.europa.eu/mt/registration-dossier/-/registered-dossier/10893/7/9/1?utm_source=openai))

Безопасен ли behenamide при грудном вскармливании?

No data show reproductive or lactation-specific hazard or systemic developmental toxicity for docosanamide; authoritative registrant assessment did not identify reproductive concerns and there is no harmonised classification. In absence of evidence, default CIR/SCCS-level concerns are not present. ([echa.europa.eu](https://echa.europa.eu/mt/registration-dossier/-/registered-dossier/10893/7/9/1?utm_source=openai))

Безопасен ли behenamide для кожи малыша?

No evidence of infant-specific hazard was found. Docosanamide is a long-chain (C22) primary fatty‑acid amide with very high estimated lipophilicity and low water solubility (low likelihood of systemic uptake from topical use), but because infant skin has a less mature barrier and higher surface‑area‑to‑weight ratio, exposure scoring is raised by +1 for babies versus adults. No studies demonstrate placental transfer, endocrine activity, or developmental toxicity. ([pubchem.ncbi.nlm.nih.gov](https://pubchem.ncbi.nlm.nih.gov/compound/EINECS%20221-304-1?utm_source=openai))

Как VeriMom оценивает behenamide?

VeriMom оценивает behenamide в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.

Какие безопасные альтернативы behenamide при беременности?

См. наш список безопасных альтернатив behenamide с аналогичной функцией и классификацией без известных рисков.